Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer - Publication

Publication

Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

Journal Paper/Review - Nov 6, 2020

Tesch Hans, Luftner Diana, Schneeweiss Andreas, Lux Michael P, Fehm Tanja N, Overkamp Friedrich, Welslau Manfred, Schulmeyer Carla E, Kolberg Hans-Christian, Fasching Peter A, Huober Jens, Thill Marc, Hartkopf Andreas, Schütz Florian, Belleville Erik, Ettl Johannes, Wöckel Achim, Müller Volkmar, Janni Wolfgang

Citation

Tesch H, Luftner D, Schneeweiss A, Lux M, Fehm T, Overkamp F, Welslau M, Schulmeyer C, Kolberg H, Fasching P, Huober J, Thill M, Hartkopf A, Schütz F, Belleville E, Ettl J, Wöckel A, Müller V, Janni W. Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer. Geburtshilfe Frauenheilkd 2020; 80:1115-1122.

Type

Journal Paper/Review (English)

Journal

Geburtshilfe Frauenheilkd 2020; 80

Publication Date

Nov 6, 2020

Issn Print

0016-5751

Pages

1115-1122

Brief description/objective

Substances with good effectiveness that intervene in specific signalling pathways have been used increasingly in recent years in the treatment of patients with advanced breast cancer, and new therapies and approaches have now been added, which actually relate to quite specific changes, such as the treatment of patients with HR+/HER2 tumours with a mutation. The treatment of patients with a or mutation has also been improved by the introduction of PARP inhibitors. Attempts are now being made increasingly to extend treatment indications based on molecular patterns, to identify other patients who could benefit from a treatment and to integrate the newly established treatment methods in existing therapy sequences. This review articles summarises the latest information in this connection.